| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 2380-20-3 | | methyl 5-oxooctadecanoate | | | 58-60℃ | |
| 2380-22-5 | | methyl 7-oxooctadecanoate | | | | |
| 2380-27-0 | | methyl 12-oxooctadecanoate | C19H36O3 | 312.5 | | |
| 2380-36-1 | | 3,5-di-tert-butylaniline | C14H23N | 205.34 | 54-57℃ | 276.6ºC |
| 2380-61-2 | 硝酸硫胺ep杂质a | thiamine nitrate ep impurity a | | | | |
| 2380-63-4 | | 4-Amino-pyrazolo[3,4-d]pyrimidine | C5H5N5 | 135.12 | | |
| 2380-78-1 | | homovanillyl alcohol | C9H12O3 | 168.19 | 40-42℃ | |
| 2380-82-7 | 5-甲氧基-1H-吲哚-6-醇 | 5-Methoxy-1H-indol-6-ol | C9H9NO2 | 163.17 | | |
| 2380-84-9 | 7-羟基吲哚 | 7-hydroxyindole | C8H7NO | 133.15 | | |
| 2380-86-1 | 6-羟基吲哚 | N-(benzyloxycarbonyl)-4-(hydroxymethyl)piperidine | C8H7NO | 133.1494 | 124-130 °C | |
| 2380-91-8 | | 4-hydroxy-a-methylbenzenemethanol | C8H10O2 | 138.16 | | 270.6°C |
| 2380-94-1 | 4-羟基吲哚 | 1H-Indol-4-ol | C8H7NO | 133.15 | 97-100℃ | |
| 23800-56-8 | 4-羟基-6-甲基-3-(4-甲基-1-氧代戊基)-2h-吡喃-2-酮 | 4-hydroxy-6-methyl-3-(4-methylpentanoyl)-2h-pyran-2-one | C12H16O4 | 224.25 | | |
| 23800-57-9 | | 1,3,5-triphenyl-2-pentene-5-dione | | | | |
| 23800-93-3 | | 3-(2-chlorophenyl)-7-hydroxy-4-methyl-2h-chromen-2-one | C16H11ClO3 | 286.71 | | 500.5±50.0 °C(Predicted) |
| 23800-94-4 | | 3-(3-chlorophenyl)-7-hydroxy-4-methyl-2h-chromen-2-one | C16H11ClO3 | 286.71 | 251-252 °C | 504.3±50.0 °C(Predicted) |
| 2380000-55-3 | β-NF-JQ1 | | C45H42ClN5O6S | 816.36 | | |
| 2380027-49-4 | Src Inhibitor 3 | | C34H32ClFN8O4 | 671.12 | | |
| 2380163-04-0 | 3,6-双(二甲基氨基)-9-(2,6-二甲基苯基)-10-甲基a啶-10-鎓溴化物 | 3,6-bis(dimethylamino)-9-(2,6-dimethylphenyl)-10-methylacridin-10-ium bromide | | | | |
| 23802-14-4 | | 4-sec-butyl-alpha-(p-chlorophenyl)-o-creso | | | | |
| 23802-15-5 | | 7-(p-chlorophenyl)-m-cymen-6-o | | | | |
| 23802-17-7 | | 7-(2,4-dichlorophenyl)-m-cymen-6-o | | | | |
| 23802-18-8 | | 4-tert-butyl-alpha-(2,4-dichlorophenyl)-o-creso | | | | |
| 23802-20-2 | | 4-tert-butyl-alpha-(3,4-dichlorophenyl)-o-creso | | | | |
| 23802-21-3 | | 4-sec-butyl-alpha-(3,4-dichlorophenyl)-o-creso | | | | |
| 23802-22-4 | | 4-tert-butyl-6-chloro-alpha-(2,4-dichlorophenyl)-o-creso | | | | |
| 2380225-24-9 | (1R,2R)-1,2-二([1,1'-联苯]-2-基)乙烷-1,2-二胺 | (1R,2R)-1,2-di([1,1'-biphenyl]-2-yl)ethane-1,2-diamine | C26H24N2 | 364.49 | | 578.3±50.0 °C(Predicted) |
| 2380228-45-3 | N-(4-(萘-2-基甲基)苯基)乙烯磺酰胺 | N-(4-(Naphthalen-2-ylmethyl)phenyl)ethenesulfonamide | C19H17NO2S | 323.41 | | 501.7±53.0 °C(Predicted) |
| 2380230-73-7 | NF-56-EJ40 | | C27H29N3O3 | 443.54 | | |
| 2380267-91-2 | (1-环丙基-1H-吡唑-3-基)氨基甲酸叔丁酯 | tert-Butyl (1-cyclopropyl-1H-pyrazol-3-yl)carbamate | C11H17N3O2 | 223.272 | | 308.0±15.0 °C(Predicted) |
| 2380273-26-5 | (2S,4S)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺盐酸盐 | (2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride | C23H33ClN4O3S | 481.05 | | |
| 2380273-44-7 | 9-(((S)-1-((2S,4R)-4-羟基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-9-氧代壬酸 | 9-(((S)-1-((2S,4R)-4-Hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-9-oxononanoic acid | C32H46N4O6S | 614.8 | | |
| 2380273-45-8 | 10-(((S)-1-((2S,4R)-4-羟基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-10-氧代十二烷酸 | 10-(((S)-1-((2S,4R)-4-Hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-10-oxodecanoic acid | C33H48N4O6S | 628.82 | | |
| 2380273-50-5 | (2S,4R)-1-((S)-2-(6-氨基己酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺 盐酸盐 | (2S,4R)-1-((S)-2-(6-Aminohexanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride | C29H44ClN5O4S | 594.21 | | |
| 2380273-67-4 | 2-(2-氨基乙氧基)-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)乙酰胺盐酸盐 | 2-(2-Aminoethoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide hydrochloride | C17H19ClN4O6 | 410.81 | | |
| 2380273-72-1 | Thalidomide-amido-PEG2-NH2 | | C19H22N4O7 | 418.40 | | |
| 2380273-73-2 | Thalidomide-amido-PEG2-NH2 hydrochloride | | C19H23ClN4O7 | 454.86 | | |
| 2380273-74-3 | Pomalidomide-amino-PEG3-NH2 | | C21H26N4O8 | 462.45 | | |
| 2380273-75-4 | Pomalidomide-amino-PEG3-NH2 hydrochloride | | C21H27ClN4O8 | 498.92 | | |
| 2380273-78-7 | 3-溴-N-(2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)丙酰胺 | 3-Bromo-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)propanamide | | | | |
| 2380274-50-8 | (2S,4R)-1-((S)-2-(2-(4-(3-氨基-6-(2-羟基苯基)哒嗪-4-基)哌嗪-1-基)乙酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺 | (2S,4R)-1-((S)-2-(2-(4-(3-Amino-6-(2-hydroxyphenyl)pyridazin-4-yl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide | C39H49N9O5S | 755.92 | | |
| 2380275-60-3 | 5,5'-(1,4-亚苯基双(乙炔-2,1-二基))二间苯二甲醛 | 5,5'-(1,4-Phenylenebis(ethyne-2,1-diyl))diisophthalaldehyde | | | | |
| 2380275-62-5 | | [1,1':4',1''-terphenyl]-3,3'',5,5''-tetracarbaldehyde | C22H14O4 | 342.34 | | |
| 23803-42-1 | | tris(8-quinolinolato-n(sup 1),n(sup 8))-antimon | | | | |
| 2380300-79-6 | 4-(3-(((2-氨基-5-(2-(1-甲基哌啶-4-基)噻唑-5-基)吡啶-3-基)氧基)甲基)苯基)-2-甲基-3-丁炔-2-醇 | 4-(3-(((2-amino-5-(2-(1-methylpiperidin-4-yl)thiazol-5-yl)pyridin-3-yl)oxy)methyl)phenyl)-2-methylbut-3-yn-2-ol | C26H30N4O2S | 462.607 | | 647.3±55.0 °C(Predicted) |
| 2380310-03-0 | 14,14-dimethyl-13-(3-methoxy-2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)-1,4-dioxa-13-phosphadispiro[4.1.5.3]pentadecane | andrewphos | | | | |
| 2380310-07-4 | 13-(2′,4′,6′-triisopropyl-3-methoxy-[1,1′-biphenyl]-2-yl)-1,4-dioxa-13-phosphatrispiro[4.1.57.1.514.15]icosane | summerphos | | | | |
| 2380318-57-8 | Thalidomide-O-PEG4-azide | | C23H29N5O9 | 519.50 | | |
| 2380321-51-5 | CDK4/6-IN-6 | | C22H27ClFN5O3 | 463.94 | | 687.4±65.0 °C(Predicted) |
| 2380322-91-6 | 5-溴-7-氟-3-异丙基-2-甲基-2H-吲唑 | 5-Bromo-7-fluoro-3-isopropyl-2-methylindazole | C11H12BrFN2 | 271.132 | | 344.8±37.0 °C(Predicted) |
m.cnreagent.com